Friends: This has been a pivotal year for Ovarian Cancer Research Alliance (OCRA), defined by powerful forward momentum—from launching the Global Ovarian Cancer Research Consortium to preparing the Community Accelerated Research Exchange for its debut, expanding essential support and education programs, and establishing our new Center for Public Policy. These developments, along with the progress highlighted below, signal a turning … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance As 2025 ends, we’re reflecting on a year marked by growth, resilience, and meaningful impact. In a complex policy environment, one thing remained constant: the dedication of OCRA’s advocates to advancing policies that strengthen care, access, and support for people impacted by ovarian and gynecologic … Continued
First-Time Participant Tackles 1,576 Steps to Honor Family and Support OCRA Earlier this year, Crystal Merope Jeffs took her support for the ovarian and gynecologic cancer community to new heights—literally—when she entered the lottery for the Empire State Building Run-Up. I decided to do something a little wild—to run up the Empire State Building. All … Continued
Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued
Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued
YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care Together we are driving research breakthroughs and helping patients and families facing gynecologic cancer to access critical support. Your generous donation brings us one step closer to reaching our important $2 million year-end fundraising goal, and an even more impactful 2026. Ovarian Cancer … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update: Government Shutdown Ends — What It Means for the Cancer Community As you are no doubt aware, after 43 days, the federal government shutdown officially ended. On November 12, 2025, President Donald J. Trump signed the temporary funding bill passed by Congress, reopening … Continued
New policy hub builds on record of helping to secure billions in federal funding and training thousands of advocates, with expanded priorities and an interactive policy map New York, NY – [November 20, 2025] — Ovarian Cancer Research Alliance (OCRA) today announced the launch of its Center for Public Policy, a dedicated hub that reflects expanded policy … Continued
In 2025, Ovarian Cancer Research Alliance (OCRA) invested more than $10.8 million toward scientific research—part of our $14.5 million commitment to strengthen the community through research, patient support, education and advocacy. This year’s investment represents OCRA’s broadest scope to date, encompassing not only our renowned grant programs but also global collaborations leveraging artificial intelligence (AI) … Continued
KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update As of this writing, Congress has failed to come to an agreement on funding for the current fiscal year and the federal government is in a shutdown. We are closely monitoring the impact that the shutdown is having on the patient community and … Continued
This article was updated in October 2025 to reflect NCCN’s release of the 2025 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2025 Patient Guidelines for Cervical, Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed to help … Continued
Get email updates about research news, action alerts, and ways to join the fight.
